Haemonetics (HAE) Tops Q2 EPS by 11c, Revenues Beat
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $90.27 -0.58%
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.62, $0.11 better than the analyst estimate of $0.51. Revenue for the quarter came in at $209 million versus the consensus estimate of $207.65 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
- Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
